<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02976298</url>
  </required_header>
  <id_info>
    <org_study_id>C12-05</org_study_id>
    <secondary_id>2012-A00796-37</secondary_id>
    <nct_id>NCT02976298</nct_id>
  </id_info>
  <brief_title>Effects of Cerebellum or Supplementary Motor Area Functional Inactivation on Gait and Balance Control</brief_title>
  <acronym>CERESMARCHE</acronym>
  <official_title>Rôle du Cervelet et de l'Aire Motrice supplémentaire Dans le contrôle Postural au Cours de la Marche Chez l'Homme</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut National de la Santé Et de la Recherche Médicale, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In human, the physiology of gait and balance is not clearly established. By using functional
      imaging and electrophysiological techniques, various brain regions from the cortex to the
      midbrain area, including the cerebellum, have been identified as involved in such control.
      The specific role of these structures in both the capacity to go forward (locomotion) and
      stand upright (balance), but also in the different phases of the gait initiation process, are
      not known, however. In this study,the investigators aimed to assess the specific role of both
      the supplementary motor area (SMA) and the cerebellum in postural control during the
      initiation of gait. For this purpose, the investigators plan to study the gait initiation in
      20 healthy subjects before and after functional inactivation (using inhibitory repetitive
      transcranial magnetic stimulation, rTMS) of the cerebellum or SMA. Biomechanical, kinematic
      and electromyographic parameters of the gait initiation will be recorded using a force
      platform, reflective markers with infrared cameras (VICON system) and lower limbs surface EMG
      electrodes.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Actual">January 2015</completion_date>
  <primary_completion_date type="Actual">January 2015</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>postural control during gait initiation</measure>
    <time_frame>change between baseline and 5 minutes after transcranial magnetic stimulation</time_frame>
    <description>braking capacity</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>duration of anticipatory postural adjustments</measure>
    <time_frame>change between baseline and 5 minutes after transcranial magnetic stimulation</time_frame>
    <description>duration</description>
  </secondary_outcome>
  <other_outcome>
    <measure>centre of foot pressure displacement during postural adjustments</measure>
    <time_frame>change between baseline and 5 minutes after transcranial magnetic stimulation</time_frame>
    <description>centre of foot pressure displacement measured by force platform</description>
  </other_outcome>
  <other_outcome>
    <measure>step length</measure>
    <time_frame>change between baseline and 5 minutes after transcranial magnetic stimulation</time_frame>
    <description>step length</description>
  </other_outcome>
  <other_outcome>
    <measure>step velocity</measure>
    <time_frame>change between baseline and 5 minutes after transcranial magnetic stimulation</time_frame>
    <description>step velocity</description>
  </other_outcome>
  <other_outcome>
    <measure>duration of electromyographic activity of the tibialis anterior muscles</measure>
    <time_frame>change between baseline and 5 minutes after magnetic transcranial stimulation</time_frame>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Transcranial Magnetic Stimulation</condition>
  <arm_group>
    <arm_group_label>transcranial magnetic stimulation</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>sham transcranial magnetic stimulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>supplementary motor area stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>supplementary motor area transcranial magnetic stimulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>cerebellar stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>cerebellar transcranial magnetic stimulation</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>transcranial magnetic stimulation</intervention_name>
    <description>comparison of different conditions of transcranial magnetic stimulation</description>
    <arm_group_label>transcranial magnetic stimulation</arm_group_label>
    <arm_group_label>supplementary motor area stimulation</arm_group_label>
    <arm_group_label>cerebellar stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18-70 years

          -  agree to participate to the study with signature of the informed consent

          -  heathy insurance

          -  normal clinical exam

        Exclusion Criteria:

          -  previous medical history of neurological, rheumatological, orthopedic or psychiatric
             disorders

          -  contra-indication to MRI or TMS

          -  drug treatment that modifies the nervous central system excitability (antidepressant,
             antiepileptic, neuroleptic)

          -  chronic alcoholism
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marie-Laure Welter, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>APHP</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sabine Meunier, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Institut National de la Santé Et de la Recherche Médicale, France</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>M.L.Welter</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 26, 2013</study_first_submitted>
  <study_first_submitted_qc>November 24, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 29, 2016</study_first_posted>
  <last_update_submitted>December 6, 2016</last_update_submitted>
  <last_update_submitted_qc>December 6, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 7, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cerebellum</keyword>
  <keyword>supplementary motor area</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

